Risk Factors of Bleeding Under Veno Arterial Membrane Oxygenation (ECMO bleeding)

University Hospital Center (CHU) Dijon Bourgogne

Status: Completed

Conditions: Complication; Extracorporeal Membrane Oxygenation; Bleeding

Treatments: Device: ECMO

Study type: Observational

Funder types: Other

Identifiers

NCT03888833

ELLOUZE 2019

Details and patient eligibility

About

Veno arterial extracorporeal membrane oxygenation (VA ECMO) is used, for cardiogenic shock, refractory cardiac arrest and post cardiotomy cardiac failure. Bleeding is frequent complications during VA ECMO and is associated with increased mortality. The aim of our study was to identify early factors associated with major bleeding in patients supported by VA ECMO

Enrollment: 278 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: Patients over 18 years treated by peripheral veno arterial membrane oxygenation

Exclusion Criteria: None

Trial design

278 participants in 1 patient group

Veno arterial extracorporeal membrane oxygenation

Treatment:

Device: ECMO